Bader et al., Proc. Natl. Acad. Sci., 88, 6740-6744 (1991). |
Bandara et al., Two Chemically Distinct Groups of Calophyllum Species From Sri Lanka, Phytochemistry, 25(2), 425-428 (1986). |
Barton et al., Tetrahedron Letters, 31 (51), 7449-7452 (1990). |
Boyd, “Strategies for the Identification of New Agents for the Treatment of AIDS: A National Program to Facilitate the Discovery and the Preclinical Development of New Drug Candidates for Clinical Evaluation,” (Chapter 18) In AIDS: Etiology, Diagnosis, Treatment and Prevention, 2d edition, (DeVita, Jr. et al., eds., J.B. Lippincott Co., Philadelphia, 1988). |
Boyer et al., “Analysis of Nonnucleoside Drug-Resistant Variants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,” J. Virology, 67(4), 2412-2420 (1993). |
Chaturvedi, et al., “Anticonvulsantand Antiinflammatory Activity of Natural Plant Coumarins and Triterpenoids,” Research Communications In Chemical Pathology and Pharmacology, 9(1), 11-22 (Sep. 1974). |
Chenera et al., J. Org. Chem., 58, 5605-5606 (1993). |
Cragg et al., Conservation of Biodiversity and the Potential for Development of Pharmaceutical Crops: Drug Discovery and Development at the United States National Cancer Institute, In Proceedings of the Symposium on The Industrial Utilization of Tropical Plants and the Conservation of Biodiversity, Enugu, Nigeria, Feb. 14-19, 1993. |
Craig et al., “Antiviral properties of Ro 31-8959, An Inhibitor of Human Immunodeficiency Virus (HIV) Proteinase,” Antiviral Research, 16, 295-305 (1991). |
Crombie et al., Tetrahedron Letters, 2, 151-156 (1996). |
Crombie et al., Tetrahedron Letters, 26 (24), 2929-2932 (1985). |
Dahanayake et al., “Chemical Investigation of Ceylonese Plants. Part VII. Extractives of Calophyllum thwaitesii Planch and Triana and Calophyllum walkeri Wight (Guttiferae),” J.C.S. Perkin I: 2510-2514 (1974). |
De Clercq, AIDS Research and Human Retroviruses, 8, 2: 119-134 (1992). |
Dharmaratne et al., “Xanthones from Roots of Three Calophyllum Series,” Phytochemistry, 25(8), 1957-1959 (1986). |
Dharmaratne et al., “Triterpenoids and Coumarins from the Leaves of Calophyllum Cordato-Oblongum,” Phytochemistry, 24(7), 1553-1556 (1985). |
Games et al., Tetrahedron Letters, 31, 3187-3190 (1972). |
Gautier et al., “Structure of Calphynic Acid, A Novel Constituent of Calophyllum Inophyllum,” Tetrahedron Letters, 27, 2715-2718 (1972). |
Gulakowski et al., “A Semiautomated Multiparameter Approach for Anti-HIV Drug Screening,” Journal of Virological Methods 33, 87-100 (1991). |
Gunasekera et al., “Chemical Investigation of Ceylonese Plants. Part 27. Extractives of Calophyllum cuneifolium Thw. and Calophyllum soulattri Burm. f. (Guttiferae),” J.C.S. Perkin I: 1505-1511 (1977). |
Gunasekera et al., “Chemical Investigation of Ceylonese Plants. Part XVI. Extractives of Calophyllum cordato-oblongum Thw. &Guttiferae),” J.C.S. Perkin I: 2215-2220 (1995). |
Gunatilaka et al., “Terpenoid and Biflavonoid Constituents of Calophyllum Calaba and Garcinia Spicata From Sri Lanka,” Phytochemistry, 23(1), 323-328 (1984). |
Gustafson et al. “Isolation and Identification of a New AIDS-Antiviral Agent from a Samoan Medicinal Plant, Homalanthus acuminatus,” (Chu et al., eds., Plenum Press, New York 1992). |
Gustafson et al., “A Nonpromoting Phorbol from the Samoan Medicinal Plant Homalanthus nutans Inhibits Cell Killing by HIV-1,” J. Med. Chem., 35, 1978-1986 (1992). |
Gustafson et al., “AIDS-Antiviral natural Products Research at the U.S. National Cancer Institute,” Natural Products as Antiviral Agents (Chu et al., eds., Plenum Press, New York 1992). |
Hertzberg et al., “Kinetic Studies of HIV-1 Reverse Transcriptase Inhibition by Inophyllums, A Novel Class of Non-Nucleoside Inhibitors, Using a Scintillation Proximity Assay,” Programs and Abstracts of the Third International Conference on the Biotechnology of Microbial Products: Novel Pharmacological and Agrobiological Activities, S-9, (Apr. 1993). |
Hertzberg et al., “Novel Methods for Antiviral Drug Discovery,” Programs and Abstracts of the Third International Conference on the Biotechnology of Microbial Products: Novel Pharmacological and Agrobiological Activities, S-9, 17 (Apr. 1993). |
Hizi et al., “Specific Inhibition of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 and the Chimeric Enzumes of Human Immunodeficiency Viruses Type 1 and Type 2 by Nonnucleoside Inhibitors,” Antimicrob. Agents Chemother., 37, 1037-1042 (1993). |
Kashman et al., J. Med. Chem., 36, 1110 (1993). |
Kashman et al., “The Calanolides, a Novel HIV-Inhibitory Class of Courmarin Derivatives from the Tropical Rainforest Tree, Calophyllum lanigerum,” J. Med. Chem., 35, 2735-2743 (1992). |
Kawazu et al., “Piscicidal Constituents of Capophyllum Inophyllum,” Chemical Abstracts, 78(3), 207 (Jan. 22, 1973). |
Kumar et al., “Calocalabaxanthone, The Putative Isoprenyl Precursor of Calabaxanthone From Calophyllum Calaba,” Phytochemistry, 21(3), 807-809 (1982). |
Mabberley, The Plant Book, (p. 92) (Cambridge University Press, 1987). |
McCaffrey et al., “A Rapid Fluorometric DNA Assay for the Measurement of Cell Density and Proliferation In Vitro,” In Vitro Cellular & Developmental Biology, 24(3), Part I 247-252 (Mar. 1988). |
Merigan, “Treatment of AIDS with Combinations of Antiretroviral Agents,” Amer. J. of Medicine, 90(suppl. 4A), 8S-17S (Apr. 10, 1991). |
Mitsuya et al., Science, 249, 1533-1544 (1990). |
Ohtani et al., “A New Aspect of the High-Field NMR Application of Mosher's Method. The Absolute Configuration of Marine Triterpene Sipholenol-A,” J. Org. Chem., 56, 1296-1298 (1991). |
Ohtani et al., “Absolute Configuration of Marine Diterpenes Possessing a Xenicane Skeleton. An Application of an Advanced Mosher's Method” Tetrahedron Letters, 30(24), 3147-3150 (1989). |
Palmer et al., J. Chem. Soc. Perkins Trans I, 3135-3152 (1995). |
Palmer et al., Tetrahedron Letters, 35 (30), 5363-5366 (1994). |
Patil et al., “The Inophyllums, Novel Inhibitors of HIV-1 Reverse Transcriptase,” Programs and Abstracts of the Third International Conference on the Biotechnology of Microbial Products: Novel Pharmacological and Agrobiological Activities, P-31, 26 (Apr. 1993). |
Pauwels et al., “Potent and selective inhibition HIV-1 Replication In Vitro by A Novel Series of TIBO Derivatives,” Nature, 343, 470-474 (1990). |
Ranjith et al., Phytochemistry, 24(7), 1553-1556 (1985). |
Richman, Annu. Rev. Med., 42, 69-90 (1991). |
Rink et al., “Cytoplasmic pH and Free Mg2+ in Lymphocytes,” The Journal of Cell Biology, 95, 189-196 (Oct. 1982). |
Samaraweera et al., “Calozeylanic Acid, A New Bark Acid From Three Calophyllum Species,” Tetraderon Letters, 22(50) 5083-5086 (1981). |
Saunders, “Non-nucleoside Inhibitors of HIV Reverse Transcriptase: Screening, Successes and Clinical Failures,” Drug Design & Discovery, 8, 255-263 (1992). |
Shih et al., “Chimeric Human Immunodeficiency Virus Type 1/Type 2 Reverse Transcriptases Display Reversed Sensitivity to Nonnucleoside Analog Inhibitors,” Proc. Natl. Acad. Sci. USA, 88, 9878-9882 (Nov. 1991). |
Soejarto et al., “Challenges in Developing a New Drug from Tropical Rain Forest Plants,” In Proceedings of the Symposium on the Industrial Utilization of Tropical Plants and the Conservation of Biodiversity, Enugu, Nigeria, Feb. 14-19, 1993. |
Somanathan et al., “Chemical Investigation of Ceylonese Plants. Part VIII. Trapezifolixanthone, a New Di-isoprenylated Xanthone from the Bark of Calophyllum trapezifolium Thw. (Guttiferae),” J.S.C. Perkin I: 2515-2517 (1974). |
Stout et al., “Calophyllum Product III. The Structures of Blanoic Acids” Journal of Organic Chemistry, 33, 4185-4190 (1968). |
Stout et al., “The Structure of Costatolide,” J. of Organic Chemistry, 29, 3604-3609 (1964). |
Swagler et al., “Pharmacokinetics of Anti-HIV Nucelosides in Microswine,” J. Pharm. Pharmacol., 43 823-826 (1991). |
Vydac Reverse Phase LPLC Brochure, 26-27 (1992). |
Weislow et al., “New Soluble-Formazan Assay for HIV-1 Cytophatic Effects: Application to High-Flux Screenings of Synthetic and Natural Products for AIDS-Antiviral Activity,” J. National Cancer Institute, 81(8), 577-586 (Apr. 19, 1989). |
White et al., “A TIBO Derivative, R82913, Is A Potent Inhibitor of HIV-1 Reverse Transcriptase with Heteropolymer Templates,” Antiviral Research, 16 257-266 (1991). |